Predictive value of MITF gene amplification in metastatic melanoma patients receiving endostar and dacarbazine as first-line treatment
A phase Ⅱ, randomized study suggests that recombinant human endostatin(endostar)plus dacarbazine can yield a significant improvement in PFS and OS.Intratumoral Microphthalmia-associated transcription factor(MITF)might be a predictive biomarker of this regimen because of upregulation of hypoxia-inducible factor 1α, which contributes to angiogenesis and disease progression.melanoma patients.
Chuanliang Cui Jiafang Ma Yan Kong Lu Si Zhihong Chi Xinan Sheng Bixia Tang Lili Mao Siming Li Bin Lian Jun Guo
Department of Renal cancer and Melanoma, Peking University School of Oncology,Beijing Cancer Hospital & Institute
国内会议
厦门
英文
605-605
2013-09-25(万方平台首次上网日期,不代表论文的发表时间)